stock offering
Myriad Genetics to Raise $110M in Public Stock Offering
The Salt Lake City-based genetic testing and precision medicine company is offering 6,470,588 shares of its common stock at a public offering price of $17 per share.
Natera Launches $250M Follow-On Stock Offering at $55 Per Share
Natera is offering 4,550,000 common shares at $55 per share in the offering, which is expected to close Sept. 11, with additional shares available to the underwriters.
Akoya Biosciences Reduces Workforce; Plans to Raise $44M in Public Offering
The company has completed a moderate restructuring across all levels and departments as part of its effort to drive efficiency but declined to provide further details, such as the number of staff terminated.
VolitionRx Prices $16.5M Public Offering
The company plans to use the proceeds of the offering for R&D, working capital, and general corporate purposes, among other things.
Biocept Prices $5M Public Offering
The San Diego-based company plans to use the proceeds to advance its cerebral spinal fluid liquid biopsy assay, as well as to boost its working capital.